MannKind's Mann Interview About Inhaled Insulin

Loading player, please wait...

Recommended Videos

  • Info

  • Comments

Jan. 10 (Bloomberg) -- Alfred Mann, chief executive officer of MannKind Corp., talks about prospects for U.S. Food and Drug Administration approval of the company's inhaled insulin. U.S regulators delayed a decision on the diabetes drug, Afrezza, on Dec. 28. Mann talks with Shannon Pettypiece on Bloomberg Television's "Street Smart." Bloomberg's Carol Massar and Matt Miller also speaks. (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change